If your child is taking medication for attention deficit hyperactivity disorder (ADHD), their doctor may soon offer a new option: fruit-flavored chewables.

The new drug, Adzenys, got FDA approval in January, and went on the market last week. But some psychiatrists are concerned that making amphetamines in a candy-like form will make people more likely to abuse them, and also contribute to what some see as a trend of overmedicating children.

Here & Now’s Robin Young talks with Meghana Keshavan, biotech correspondent at STAT.

Guest

Copyright 2016 NPR. To see more, visit NPR.

300x250 Ad

Support quality journalism, like the story above, with your gift right now.

Donate